Covered recipient · General Payments record
ASHLEIGH FARRIS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,974.59
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $327.62 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $88.80 | 5 |
| Lilly USA, LLC | $56.28 | 3 |
| Astellas Pharma US Inc | $54.42 | 2 |
| ABBVIE INC. | $49.49 | 2 |
| Acerta Pharma LLC | $37.70 | 2 |
| Exact Sciences Corporation | $21.85 | 1 |
| ACADIA Pharmaceuticals Inc | $19.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.00 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107091786 | CMS |
| ABBVIE INC. | $29.49 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107091788 | CMS |
| ACADIA Pharmaceuticals Inc | $19.08 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148003320 | CMS |
| Astellas Pharma US Inc | $30.62 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139502550 | CMS |
| Astellas Pharma US Inc | $23.80 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139502186 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.50 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104750766 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.20 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104339610 | CMS |
| Exact Sciences Corporation | $21.85 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114653916 | CMS |
| Lilly USA, LLC | $22.23 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135559236 | CMS |
| Lilly USA, LLC | $19.00 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135568252 | CMS |
| Lilly USA, LLC | $15.05 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135551411 | CMS |
| Novo Nordisk Inc | $18.67 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100520153 | CMS |
| Novo Nordisk Inc | $18.80 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100498847 | CMS |
| Novo Nordisk Inc | $16.18 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100517217 | CMS |
| Novo Nordisk Inc | $16.20 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100577626 | CMS |
| Novo Nordisk Inc | $18.95 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100546636 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.